MedPath

Correlation Between the Polymorphism ofβ2 AR and the Labor Progress After Labor Analgesia

Conditions
Labor Analgesia
Interventions
Genetic: β2AR polymorphism
Registration Number
NCT02708602
Lead Sponsor
Nanjing Maternity and Child Health Care Hospital
Brief Summary

Labor and delivery is a unique physiological experience of women. Inappropriate length of labor progress during vaginal delivery may produce great risks for mother and fetus. Especially the slow progress is one of the most important reasons for the occurrence of cesarean section during vaginal delivery, which still with a high incidence in recent years.Previous studies have found that there was a significant correlation between the genetic polymorphisms of β 2-adrenergic receptor (β2AR) and the duration of vaginal delivery.Therefore, the researchers intend to investigate the distribution of β2-adrenergic receptor (β2AR) genetic polymorphisms among Chinese parturient and observe the relationship between the genetic polymorphisms and labor process after labor analgesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
300
Inclusion Criteria
  • Nulliparous women
  • Required labor analgesia
  • Chinese
  • Spontaneous labor
Exclusion Criteria
  • Contraindications for epidural analgesia
  • Allergic to opioids and/or local anesthetics
  • Failed to performing epidural catheterization
  • Organic dysfunction
  • Those who were not willing to or could not finish the whole study at any time
  • Using or used in the past 14 days of the monoamine oxidase inhibitors
  • Alcohol addictive or narcotic dependent patients
  • Subjects with a nonvertex presentation or scheduled induction of labor
  • Twin gestation and breech presentation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
β2AR Gln27Glu (CG group)β2AR polymorphismPeople with β2AR Gln27Glu genotype.
β2AR Glu27Glu (GG group)β2AR polymorphismPeople with β2AR Glu27Glu genotype.
β2AR Arg16Arg (AA group)β2AR polymorphismPeople with β2AR Arg16Arg genotype.
β2AR Arg16Gly (AG group)β2AR polymorphismPeople with β2AR Arg16Gly genotype.
β2AR Gly16Gly (GG group)β2AR polymorphismPeople with β2AR Gly16Gly genotype.
β2AR Gln27Gln (CC group)β2AR polymorphismPeople with β2AR Gln16Gln genotype.
Primary Outcome Measures
NameTimeMethod
total labor processup to about 24h

time from the regular uterus contractions until completed childbirth, assessed up to about 24h

duration of the first stageup to about 20h

time from the regular uterus contractions to full cervix dilation,assessed up to about 20h

duration of the second stageup to about 2h

time from full cervix dilation to the complete childbirth, assessed up to about 2h

Maternal visual analogue scaleAt time of initiation of analgesia and hourly thereafter until 2 hours postpartum (approximately 10 hours)

At time of initiation of analgesia and hourly thereafter until 2 hours postpartum (approximately 10 hours)

Secondary Outcome Measures
NameTimeMethod
Neonatal weightAt delivery

At delivery

Use of oxytocin after analgesiaAt twenty-four hours postpartum

At twenty-four hours postpartum

Neonatal Apgar scaleAt the first and fifth minutes after baby was born

At the first and fifth minutes after baby was born

Maximal oxytocin doseAt twenty-four hours postpartum

At twenty-four hours postpartum

Maternal heart rate, respiratory rate, and blood pressureAt time of initiation of analgesia and hourly thereafter until 4 hours postpartum (approximately 12 hours)

At time of initiation of analgesia and hourly thereafter until 4 hours postpartum (approximately 12 hours)

method of deliveryAt time of placental delivery

At time of placental delivery

Maternal modified Bromage scaleAt time of initiation of analgesia and hourly thereafter until 2 hours postpartum (approximately 10 hours)

At time of initiation of analgesia and hourly thereafter until 2 hours postpartum (approximately 10 hours)

Rescue boluses, n of rescue boluses, and the consumption of the ropivacaine/sufentanil mixtureAt two hours postpartum

At two hours postpartum

Maternal satisfaction with analgesiaAt two hours postpartum

At two hours postpartum

© Copyright 2025. All Rights Reserved by MedPath